Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Scope Prices Hiked Following Superbug Outbreaks

April 12, 2016 By Andy Szal, Digital Reporter

A Japanese medical device company is under fire after they reportedly hiked prices for scopes that were intended to replace tainted devices linked to an outbreak of drug-resistant bacteria. The Los Angeles Times, citing emails obtained from the University of California-Los Angeles, recently reported that that Olympus Corp. charged UCLA’s Ronald Reagan Medical Center 28 percent more for the new scopes.

Three died and five others were sickened by bacteria in the scopes, which were snaked down patients’ throats during gastrointestinal procedures. After doctors found the source of the outbreak, the center asked Olympus to replace the scopes. Instead, the company offered to sell UCLA 35 more for $1.2 million, or $33,470 per scope. The university had purchased Olympus scopes for $26,200 each just 11 months earlier. In addition, the report suggested that Olympus aggressively sought to sell scopes amid as hospitals bought new devices in response to the crisis. Olympus only recalled the scopes in January — roughly one year after UCLA doctors identified the problem.
 
Olympus had long been a partner of UCLA, but that relationship soured in the wake of the outbreak, according to the emails. University officials told the Times that it switched to rival Pentax to purchase new scopes, but that some Olympus scopes remain in use at Reagan.

Olympus spokesman Mark Miller, meanwhile, attributed strong recent financial results to new products — rather than on hospitals’ high demand for new scopes — and told the Times that the emails with UCLA “represent standard business discussions within Olympus and between company personnel and customers.”

The company also reportedly blamed UCLA doctors for the outbreak in the first of several wrongful death cases. UCLA countered that Olympus never raised concerns about its cleaning procedures. The pricing allegations, meanwhile, are just the latest problem for Olympus.

A U.S. Senate report in January linked its tainted scopes to 25 outbreaks, and the company last month agreed to pay $646 million over alleged illegal payments to doctors and hospitals in the U.S. and Latin America.

This article originally appeared in Surgical Products.

Related Articles Read More >

Lazurite ArthroFree wireless surgical camera system Minnetronix Medical
How Minnetronix Medical helped Lazurite with its wireless surgical camera
Medtronic Hugo robot-assisted surgery system
The road to a robot: Medtronic’s development process for its Hugo RAS system
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A portrait of Stryker executive Tracy Robertson
Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech